Preclinical RA individuals on average have increased levels of both pro-inflammatory and anti-inflammatory cytokines, such as IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12, TNF-α, and IFN-γ. Here, IL4 is linked to rheumatoid arthritis.